Related Experiment Videos
Cholesterol embolization following coronary angioplasty
D F Fuks1, R E Griguoli, R A Borracci
1Department of Cardiovascular Surgery, H. Pombo de Rodríguez Foundation, Academia Nacional de Medicina, Buenos Aires, Argentina.
Summary
Cholesterol emboli syndrome, a rare complication after vascular procedures in patients with atherosclerosis, presents with diverse symptoms. Early anticoagulant therapy can improve patient outcomes.
Area of Science:
- Cardiology
- Vascular Surgery
- Nephrology
Background:
- Cholesterol emboli syndrome (CES) is an infrequent complication following invasive vascular procedures or surgery in patients with underlying atherosclerotic disease.
- It arises from the obstruction of small arteries by cholesterol crystals, leading to a range of clinical manifestations.
Observation:
- Clinical features of CES include livedo reticularis, "purple toe" syndrome, renal failure, and potential involvement of the gastrointestinal tract, coronary arteries, or central nervous system.
- Associated laboratory findings often include elevated erythrocyte sedimentation rate, eosinophilia, increased BUN and creatinine in renal failure cases, and elevated creatine phosphokinase suggesting muscle involvement.
Findings:
- Pathological findings typically reveal disseminated microemboli composed primarily of cholesterol crystals.
- A reported case details CES occurring post-left heart catheterization and percutaneous transluminal coronary angioplasty, presenting with acute purplish toe discoloration, livedo reticularis, and renal failure within 24 hours.
Implications:
- Prognosis in CES is contingent upon the extent of systemic involvement.
- Prevention strategies and prompt anticoagulant therapy are crucial for managing this condition and improving patient outcomes.